In rare instances, South Africa variant may evade Pfizer vaccine, researchers say
(NEW YORK) -- The first real-world study pitting COVID-19 variants against the Pfizer vaccine showed that the variant first detected in South Africa may be able to evade some vaccine protection, new research conducted in Israel found.
While "breakthrough" COVID-19 cases, meaning people who get... Read More.